Justin Champagnie: Everything you need to know

Justin Champagnie

#9 SF

Washington Wizards

Status

ACTIVE

STATS

Career Averages

PTS

REB

AST

BLK

STL

7.1

4.6

1.0

0.5

0.8

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2025-26	69	19	20.0	8.7	5.6	1.2	0.6	0.9	0.7	4	0.8	2.4	31.9%	2.6	4.3	60.5%	3.4	6.7	50.2%	1.2	1.5	78.4%	2.1	3.5	1.7	1.9	-294	58.9%
2024-25	62	31	21.6	8.8	5.7	1.0	0.6	1.0	0.9	8	1.2	3.1	38.3%	2.2	3.5	62.4%	3.4	6.6	51.1%	0.8	1.2	68.5%	1.8	3.9	1.8	1.1	-288	61.4%
2023-24	15	1	15.7	5.9	3.5	1.3	0.6	0.7	0.7	0	0.9	3.0	28.9%	1.3	2.2	57.6%	2.1	5.2	41.0%	0.8	1.0	80.0%	1.3	2.3	0.9	1.9	-59	52.6%
2022-23	5	0	6.8	2.2	1.6	0.8	0.0	0.2	0.0	0	0.2	1.0	20.0%	0.8	2.0	40.0%	1.0	3.0	33.3%	0.0	0.0	0.0%	0.6	1.0	0.4	4.0	-4	36.7%
2021-22	36	0	7.8	2.3	2.0	0.3	0.1	0.2	0.2	0	0.3	0.8	35.7%	0.6	1.1	53.8%	0.9	1.9	46.3%	0.3	0.3	100.0%	1.0	1.0	0.9	1.4	+49	57.1%
Career	187	51	17.5	7.1	4.6	1.0	0.5	0.8	0.6	12	0.8	2.3	34.6%	1.9	3.2	60.2%	2.7	5.5	49.4%	0.8	1.1	75.9%	1.7	3.0	1.5	1.5	-596	59.0%

Career Averages

PTS

REB

AST

BLK

STL

0.5

0.0

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	TD3	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2022-23	4	0	2.5	0.5	0.0	0.0	0.0	0.0	0.0	0	0	0.0	0.8	0.0%	0.3	0.3	100.0%	0.3	1.0	25.0%	0.0	0.0	0.0%	0.0	0.0	0.5	0.0	+0	25.0%
Career	4	0	2.5	0.5	0.0	0.0	0.0	0.0	0.0	0	0	0.0	0.8	0.0%	0.3	0.3	100.0%	0.3	1.0	25.0%	0.0	0.0	0.0%	0.0	0.0	0.5	0.0	+0	25.0%

Preseason
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
10/16	DET	L 119-98	16	5	1	0	0	1	0	2	0	0.0%	1	1	100.0%	3	1	33.3%	4	3	75.0%	0	1	0.0	-20	2	4	52.5%
10/13	NYK	W 120-103	22	10	7	2	2	0	0	4	1	25.0%	4	3	75.0%	8	4	50.0%	1	1	100.0%	2	5	0.0	+32	1	16	59.2%
Preseason Totals			19.6	7.5	4.0	1.0	1.0	0.5	0.0	3.0	0.5	16.7%	2.5	2.0	80.0%	5.5	2.5	45.5%	2.5	2.0	80.0%	1.0	3.0	2.0	+12	1.5	12.0	56.8%

Regular Season
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
4/9	CHI	L 119-108	17	11	8	2	0	0	1	4	1	25.0%	7	4	57.1%	11	5	45.5%	0	0	0.0%	3	5	2.0	+10	1	13	50.0%
4/7	CHI	L 129-98	29	5	8	2	2	1	1	5	1	20.0%	4	1	25.0%	9	2	22.2%	0	0	0.0%	1	7	2.0	-14	2	8	27.8%
4/4	MIA	L 152-136	20	12	10	2	0	1	0	2	1	50.0%	7	3	42.9%	9	4	44.4%	3	3	100.0%	6	4	0.0	-12	2	17	58.1%
4/1	PHI	L 153-131	20	17	7	0	2	1	0	1	0	0.0%	9	7	77.8%	10	7	70.0%	5	3	60.0%	3	4	0.0	+5	0	26	69.7%
3/30	LAL	L 120-101	26	18	4	2	0	1	0	2	1	50.0%	10	7	70.0%	12	8	66.7%	1	1	100.0%	1	3	0.0	+11	2	18	72.3%
3/29	POR	L 123-88	24	10	2	1	1	0	0	2	1	50.0%	6	3	50.0%	8	4	50.0%	1	1	100.0%	0	2	0.0	-11	2	9	59.2%
3/27	GSW	L 131-126	25	6	2	3	0	0	2	4	0	0.0%	4	3	75.0%	8	3	37.5%	0	0	0.0%	0	2	1.5	+6	3	2	37.5%
3/21	OKC	L 132-111	13	3	1	1	0	1	0	1	1	100.0%	2	0	0.0%	3	1	33.3%	0	0	0.0%	1	0	0.0	-2	1	0	50.0%
3/17	DET	L 130-117	29	18	9	2	1	0	1	4	2	50.0%	7	4	57.1%	11	6	54.5%	4	4	100.0%	2	7	2.0	-9	3	22	70.5%
3/14	BOS	L 111-100	21	10	4	1	0	2	0	1	0	0.0%	5	3	60.0%	6	3	50.0%	5	4	80.0%	0	4	0.0	+8	2	12	61.0%
3/12	ORL	L 136-131	17	12	4	1	0	1	0	1	0	0.0%	8	6	75.0%	9	6	66.7%	0	0	0.0%	4	0	0.0	+3	0	15	66.7%
3/10	MIA	L 150-129	18	8	5	2	0	1	2	2	0	0.0%	5	3	60.0%	7	3	42.9%	2	2	100.0%	1	4	1.0	-7	3	7	50.8%
3/3	ORL	L 126-109	22	13	8	1	3	1	0	2	0	0.0%	7	6	85.7%	9	6	66.7%	1	1	100.0%	4	4	0.0	+1	2	21	68.9%
3/2	HOU	L 123-118	26	12	2	2	1	3	2	3	2	66.7%	4	3	75.0%	7	5	71.4%	0	0	0.0%	2	0	1.0	+3	3	12	85.7%
2/28	TOR	L 134-125	21	12	5	2	3	0	0	2	0	0.0%	9	6	66.7%	11	6	54.5%	0	0	0.0%	4	1	0.0	-13	2	14	54.5%
2/26	ATL	L 126-96	19	14	2	1	1	1	0	5	1	20.0%	6	3	50.0%	11	4	36.4%	6	5	83.3%	0	2	0.0	-20	1	11	51.3%
2/24	ATL	L 119-98	15	14	2	0	0	2	0	6	4	66.7%	2	1	50.0%	8	5	62.5%	0	0	0.0%	1	1	0.0	-19	1	14	87.5%
2/20	IND	W 131-118	10	0	7	1	0	0	2	0	0	0.0%	1	0	0.0%	1	0	0.0%	0	0	0.0%	1	6	0.5	-5	2	3	0.0%
2/11	CLE	L 138-113	24	12	8	2	0	3	1	5	2	40.0%	4	3	75.0%	9	5	55.6%	0	0	0.0%	6	2	2.0	-2	2	18	66.7%
2/8	MIA	L 132-101	24	13	7	1	0	1	0	5	1	20.0%	6	3	50.0%	11	4	36.4%	4	4	100.0%	3	4	0.0	-8	0	18	50.9%
2/7	BKN	L 127-113	22	21	9	2	2	0	3	2	1	50.0%	6	4	66.7%	8	5	62.5%	10	10	100.0%	3	6	0.7	+4	0	34	84.7%
2/5	DET	W 126-117	15	14	7	1	1	0	0	4	3	75.0%	6	2	33.3%	10	5	50.0%	1	1	100.0%	4	3	0.0	+16	0	17	67.0%
2/3	NYK	L 132-101	20	2	4	0	1	0	1	3	0	0.0%	4	1	25.0%	7	1	14.3%	2	0	0.0%	2	2	0.0	-4	2	3	12.7%
1/30	LAL	L 142-111	23	9	4	0	0	0	0	3	1	33.3%	4	3	75.0%	7	4	57.1%	0	0	0.0%	2	2	0.0	-27	2	8	64.3%
1/29	MIL	W 109-99	25	12	6	1	1	1	0	3	1	33.3%	7	4	57.1%	10	5	50.0%	2	1	50.0%	1	5	0.0	+9	2	13	55.1%
1/27	POR	W 115-111	18	1	3	1	0	1	2	1	0	0.0%	1	0	0.0%	2	0	0.0%	2	1	50.0%	1	2	0.5	-9	1	0	17.4%
1/24	CHA	L 119-115	32	15	11	3	2	3	2	3	1	33.3%	6	6	100.0%	9	7	77.8%	0	0	0.0%	3	8	1.5	+4	1	30	83.3%
1/22	DEN	L 107-97	18	3	2	3	0	1	0	2	1	50.0%	0	0	0.0%	2	1	50.0%	0	0	0.0%	1	1	0.0	+2	1	7	75.0%
1/19	LAC	L 110-106	25	9	4	0	0	1	3	2	1	50.0%	3	2	66.7%	5	3	60.0%	2	2	100.0%	0	4	0.0	-10	2	9	76.5%
1/17	DEN	L 121-115	26	13	9	1	0	3	2	3	0	0.0%	8	6	75.0%	11	6	54.5%	1	1	100.0%	3	6	0.5	+1	0	20	56.8%
1/16	SAC	L 128-115	26	15	7	2	0	0	0	3	1	33.3%	8	6	75.0%	11	7	63.6%	0	0	0.0%	2	5	0.0	-12	4	15	68.2%
1/14	LAC	L 119-105	26	7	8	1	1	0	1	3	1	33.3%	4	2	50.0%	7	3	42.9%	0	0	0.0%	3	5	1.0	-22	1	10	50.0%
1/11	PHX	L 112-93	21	8	6	0	0	1	1	0	0	0.0%	6	3	50.0%	6	3	50.0%	2	2	100.0%	2	4	0.0	-18	1	9	58.1%
1/9	NOP	L 128-107	21	12	9	4	0	0	0	2	0	0.0%	10	6	60.0%	12	6	50.0%	0	0	0.0%	3	6	0.0	-5	1	18	50.0%
1/7	PHI	L 131-110	25	6	5	2	1	1	2	2	0	0.0%	5	3	60.0%	7	3	42.9%	0	0	0.0%	2	3	1.0	-25	3	4	42.9%
1/6	ORL	W 120-112	22	17	3	3	2	0	1	5	4	80.0%	2	2	100.0%	7	6	85.7%	2	1	50.0%	2	1	3.0	+10	5	19	107.9%
1/4	MIN	L 141-115	18	6	6	0	2	0	0	2	0	0.0%	4	3	75.0%	6	3	50.0%	1	0	0.0%	2	4	0.0	-23	1	9	46.6%
1/2	BKN	W 119-99	24	20	7	0	1	1	2	3	2	66.7%	9	7	77.8%	12	9	75.0%	0	0	0.0%	4	3	0.0	+7	4	18	83.3%
12/31	MIL	W 114-113	32	12	9	2	2	2	0	3	1	33.3%	6	4	66.7%	9	5	55.6%	2	1	50.0%	3	6	0.0	+4	1	21	60.7%
12/29	PHX	L 115-101	26	11	6	0	0	1	0	4	1	25.0%	5	3	60.0%	9	4	44.4%	4	2	50.0%	2	4	0.0	-5	3	9	51.1%
12/28	MEM	W 116-112	25	10	12	0	1	1	2	4	2	50.0%	4	1	25.0%	8	3	37.5%	2	2	100.0%	4	8	0.0	-2	3	14	56.3%
12/26	TOR	W 138-117	22	8	7	2	1	1	0	2	2	100.0%	2	1	50.0%	4	3	75.0%	0	0	0.0%	1	6	0.0	+10	2	15	100.0%
12/23	CHA	L 126-109	19	10	9	0	0	0	0	1	0	0.0%	6	5	83.3%	7	5	71.4%	0	0	0.0%	5	4	0.0	-7	3	14	71.4%
12/21	SAS	L 124-113	20	5	3	1	0	0	0	3	0	0.0%	3	2	66.7%	6	2	33.3%	2	1	50.0%	1	2	0.0	-5	2	2	36.3%
12/20	MEM	W 130-122	23	4	11	4	1	1	1	3	1	33.3%	2	0	0.0%	5	1	20.0%	4	1	25.0%	5	6	4.0	-2	2	13	29.6%
12/18	SAS	L 119-94	17	5	9	0	1	0	1	2	0	0.0%	2	2	100.0%	4	2	50.0%	2	1	50.0%	3	6	0.0	-6	0	13	51.2%
12/14	IND	W 108-89	33	13	14	0	1	2	0	3	1	33.3%	10	5	50.0%	13	6	46.2%	0	0	0.0%	3	11	0.0	+23	2	21	50.0%
12/12	CLE	L 130-126	17	3	7	1	0	1	0	3	1	33.3%	1	0	0.0%	4	1	25.0%	0	0	0.0%	1	6	0.0	+0	4	6	37.5%
12/6	ATL	L 131-116	32	16	5	3	3	1	0	3	2	66.7%	6	4	66.7%	9	6	66.7%	3	2	66.7%	1	4	0.0	-16	3	24	77.5%
12/4	BOS	L 146-101	15	9	7	1	0	1	1	1	0	0.0%	5	3	60.0%	6	3	50.0%	3	3	100.0%	1	6	1.0	-1	0	17	61.5%
12/2	PHI	L 121-102	23	13	7	1	1	1	3	5	2	40.0%	4	1	25.0%	9	3	33.3%	5	5	100.0%	3	4	0.3	-7	0	16	58.0%
12/1	MIL	W 129-126	19	10	8	2	2	1	0	1	0	0.0%	7	5	71.4%	8	5	62.5%	0	0	0.0%	6	2	0.0	+3	1	19	62.5%
11/28	IND	L 119-86	11	0	2	0	0	1	0	1	0	0.0%	0	0	0.0%	1	0	0.0%	0	0	0.0%	0	2	0.0	-2	0	1	0.0%
11/25	ATL	W 132-113	17	4	5	1	1	1	0	1	0	0.0%	2	2	100.0%	3	2	66.7%	0	0	0.0%	1	4	0.0	-7	0	11	66.7%
11/22	CHI	L 121-120	23	2	5	2	1	2	1	1	0	0.0%	2	1	50.0%	3	1	33.3%	0	0	0.0%	2	3	2.0	-11	3	5	33.3%
11/21	TOR	L 140-110	18	7	3	4	0	2	0	2	0	0.0%	4	3	75.0%	6	3	50.0%	1	1	100.0%	1	2	0.0	-2	3	11	54.3%
11/16	BKN	L 129-106	6	4	0	0	0	0	0	1	0	0.0%	2	1	50.0%	3	1	33.3%	2	2	100.0%	0	0	0.0	-15	0	2	51.5%
11/12	HOU	L 135-112	3	0	1	0	0	0	0	0	0	0.0%	1	0	0.0%	1	0	0.0%	0	0	0.0%	0	1	0.0	-1	0	0	0.0%
11/10	DET	L 137-135	2	0	0	0	0	0	0	0	0	0.0%	0	0	0.0%	0	0	0.0%	2	0	0.0%	0	0	0.0	-11	1	2	0.0%
11/8	DAL	L 111-105	11	0	5	0	0	1	0	0	0	0.0%	0	0	0.0%	0	0	0.0%	0	0	0.0%	1	4	0.0	+11	4	3	0.0%
11/7	CLE	L 148-115	18	6	11	2	0	2	1	3	0	0.0%	3	1	33.3%	6	1	16.7%	4	4	100.0%	6	5	2.0	-15	0	17	38.7%
11/5	BOS	L 136-107	19	12	6	0	0	1	1	2	2	100.0%	2	2	100.0%	4	4	100.0%	3	2	66.7%	3	3	0.0	-9	2	17	112.8%
11/3	NYK	L 119-102	17	4	1	1	0	0	0	2	0	0.0%	1	1	100.0%	3	1	33.3%	2	2	100.0%	0	1	0.0	-24	3	2	51.5%
11/1	ORL	L 125-94	5	2	3	0	0	0	0	0	0	0.0%	3	1	33.3%	3	1	33.3%	0	0	0.0%	1	2	0.0	-7	0	2	33.3%
10/30	OKC	L 127-108	3	0	1	0	0	0	0	1	0	0.0%	0	0	0.0%	1	0	0.0%	0	0	0.0%	1	0	0.0	+1	0	0	0.0%
10/28	PHI	L 139-134	0	0	0	0	0	0	0	0	0	0.0%	0	0	0.0%	0	0	0.0%	0	0	0.0%	0	0	0.0	-4	0	0	0.0%
10/26	CHA	L 139-113	5	4	3	0	0	0	0	0	0	0.0%	1	0	0.0%	1	0	0.0%	4	4	100.0%	2	1	0.0	-6	1	7	72.5%
10/22	MIL	L 133-120	5	0	3	1	0	0	0	1	0	0.0%	2	0	0.0%	3	0	0.0%	0	0	0.0%	3	0	0.0	+2	1	0	0.0%
Regular Season Totals			19.8	8.6	5.6	1.2	0.6	0.8	0.6	2.3	0.7	32.1%	4.3	2.6	60.6%	6.6	3.3	50.7%	1.5	1.2	78.4%	2.1	3.5	1.9	-288	1.6	13.8	59.2%

Justin Champagnie: Breaking News

Champagnie was ejected from Sunday's 130-117 loss to the Cavaliers after totaling 13 points (5-14 FG, 3-10 3Pt), six rebounds, three assists and three steals in 32 minutes. Champagnie was a very useful role player for the Wizards in 2025-26. He ended up with a total of 69 appearances, posting averages of 8.7 points, 5.6 rebounds, 1.2 assists, 0.9 steals and 0.8 three-pointers in 20.0 minutes per contest. He's under contract with the Wizards for an additional two seasons.

Champagnie is in the starting lineup for Sunday's matchup with the Cavs. Bub Carrington, Will Riley, Jamir Watkins and Anthony Gill will round out the first group for Sunday's game. As a starter this season, Champagnie owns averages of 10.2 points, 6.0 rebounds, 1.2 assists and 1.1 triples per game on 51/40/91 shooting splits.

Champagnie (knee) has been removed from the injury report ahead of Sunday's game against the Cavaliers. Champagnie is set to return from a one-game absence Sunday, and he should see an uptick in minutes with Bilal Coulibaly (heel) unavailable. Per 36 minutes this season, Champagnie has averaged 15.6 points, 10.1 rebounds, 2.2 assists, 1.3 triples, 1.5 steals and 1.2 swats per game.